K2 Principal Fund’s Celularity CELU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-27,093
Closed -$2.73M 373
2021
Q1
$2.73M Buy
27,093
+7,093
+35% +$727K 0.22% 121
2020
Q4
$2.2M Hold
20,000
0.19% 148
2020
Q3
$2.1M Hold
20,000
0.31% 109
2020
Q2
$2.04M Buy
+20,000
New +$1.99M 0.32% 95

Other funds holding CELU

K2 Principal Fund's CELU Position: Q2 2021 in Review

K2 Principal Fund sold out of Celularity (CELU) in Q2 2021, closing a stake of 27,093 shares — an estimated $2.73M sold.

K2 Principal Fund first reported a position in CELU in Q2 2020 and held it in 4 quarters. The position peaked at $2.73M in Q1 2021. 33 funds tracked by Wall St. Rank hold CELU as of Q2 2021.

  • K2 Principal Fund reported no remaining Celularity position as of Q2 2021 after selling out during the quarter.
  • K2 Principal Fund sold 27,093 Celularity shares in Q2 2021, an estimated $2.73M.
  • K2 Principal Fund first reported a position in Celularity in Q2 2020 and held it in 4 quarters.
  • K2 Principal Fund's Celularity position peaked at $2.73M in Q1 2021.
  • 33 funds tracked by Wall St. Rank held Celularity as of Q2 2021.

Based on K2 Principal Fund's 13F filing for Q2 2021, filed 13 Aug 2021.